|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/29/16 Allscripts Healthcare Soluti… Inc 10-K 12/31/15 138:25M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.85M
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 70K
3: EX-10.41 Material Contract HTML 125K
5: EX-21.1 Subsidiaries List HTML 45K
6: EX-23.1 Consent of Experts or Counsel HTML 39K
7: EX-23.2 Consent of Experts or Counsel HTML 47K
4: EX-12.1 Statement re: Computation of Ratios HTML 57K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 45K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 45K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 40K
17: R1 Document and Entity Information HTML 68K
18: R2 Consolidated Balance Sheets HTML 136K
19: R3 Consolidated Balance Sheets (Unaudited) HTML 63K
(Parenthetical)
20: R4 Consolidated Statements of Operations HTML 98K
21: R5 Consolidated Statements of Comprehensive (Loss) HTML 71K
Income
22: R6 Consolidated Statements of Stockholders' Equity HTML 119K
23: R7 Consolidated Statements of Cash Flows HTML 138K
24: R8 Consolidated Statements of Cash Flows HTML 40K
(Parenthetical)
25: R9 Basis of Presentation and Significant Accounting HTML 380K
Policies
26: R10 Business Combinations and Other Investments HTML 164K
27: R11 Fixed Assets HTML 88K
28: R12 Goodwill and Intangible Assets HTML 254K
29: R13 Asset Impairment Charges HTML 52K
30: R14 Debt HTML 225K
31: R15 Income Taxes HTML 384K
32: R16 Stock Award Plans HTML 350K
33: R17 Stockholders' Equity HTML 46K
34: R18 Accumulated Other Comprehensive Loss HTML 416K
35: R19 Derivative Financial Instruments HTML 199K
36: R20 Commitments HTML 108K
37: R21 Business Segments HTML 140K
38: R22 Supplemental Disclosures HTML 111K
39: R23 Geographic Information HTML 91K
40: R24 Contingencies HTML 48K
41: R25 North American Site Consolidation Plan HTML 42K
42: R26 Quarterly Financial Information (Unaudited) HTML 318K
43: R27 Schedule II-Valuation and Qualifying Accounts HTML 97K
44: R28 Basis of Presentation and Significant Accounting HTML 444K
Policies (Policies)
45: R29 Basis of Presentation and Significant Accounting HTML 329K
Policies (Tables)
46: R30 Business Combinations and Other Investments HTML 158K
(Tables)
47: R31 Fixed Assets (Tables) HTML 89K
48: R32 Goodwill and Intangible Assets (Tables) HTML 252K
49: R33 Asset Impairment Charges (Tables) HTML 50K
50: R34 Debt (Tables) HTML 210K
51: R35 Income Taxes (Tables) HTML 385K
52: R36 Stock Award Plans (Tables) HTML 352K
53: R37 Accumulated Other Comprehensive Loss (Tables) HTML 415K
54: R38 Derivative Financial Instruments (Tables) HTML 189K
55: R39 Commitments (Tables) HTML 109K
56: R40 Business Segments (Tables) HTML 131K
57: R41 Supplemental Disclosures (Tables) HTML 86K
58: R42 Geographic Information (Tables) HTML 95K
59: R43 Quarterly Financial Information (Unaudited) HTML 316K
(Tables)
60: R44 Basis of Presentation and Significant Accounting HTML 112K
Policies - Additional Information (Detail)
61: R45 Reimbursements for Out-of-Pocket Expenses Incurred HTML 41K
as Client Services Revenue (Detail)
62: R46 Revenue Earned on Contracts in Excess of Billings HTML 45K
Included in Accounts Receivable and Other Assets
(Detail)
63: R47 Summary of Financial Assets and Liabilities HTML 75K
Measured at Fair Value on Recurring Basis (Detail)
64: R48 Unamortized Balances of Capitalized Software HTML 45K
(Detail)
65: R49 Capitalized Software Development Costs, Write Offs HTML 46K
Included in Asset Impairment Changes and
Amortization of Capitalized Software Development
Costs Included in Cost of Revenue (Detail)
66: R50 Calculations of Earnings (Loss) Per Share (Detail) HTML 74K
67: R51 Anti-Dilutive Stock Options, Restricted Stock Unit HTML 42K
Awards and Warrants Excluded from Computation of
Diluted Earnings (Loss) Per Share (Detail)
68: R52 Company Contributions to Employee Benefit Plan HTML 40K
(Detail)
69: R53 Business Combinations and Other Investments - HTML 79K
Acquisition of Oasis Medical Solutions Limited -
Additional Information (Detail)
70: R54 Business Combinations and Other Investments - HTML 98K
Acquisition of dbMotion - Additional Information
(Detail)
71: R55 Final Fair Value of Consideration Transferred for HTML 56K
Acquisition (Detail)
72: R56 Final Fair Value of Consideration Transferred for HTML 52K
Acquisition (Parenthetical) (Detail)
73: R57 Assets Acquired and Liabilities Assumed (Detail) HTML 69K
74: R58 Acquired Intangible Assets Amortization (Detail) HTML 56K
75: R59 Proforma Results (Detail) HTML 52K
76: R60 Business Combinations and Other Investments - HTML 64K
Acquisition of Jardogs - Additional Information
(Detail)
77: R61 Business Combinations and Other Investments - HTML 83K
Other Investments - Additional Information
(Detail)
78: R62 Business Combinations and Other Investments - HTML 46K
Summarized Financial Information for Equity Method
Investments - Additional Information (Detail)
79: R63 Summarized Financial Information for Equity Method HTML 67K
Investments (Detail)
80: R64 Fixed Assets (Detail) HTML 71K
81: R65 Depreciation and Amortization Expense (Detail) HTML 41K
82: R66 Goodwill and Intangible Assets (Detail) HTML 58K
83: R67 Goodwill and Intangible Assets - Additional HTML 57K
Information (Detail)
84: R68 Changes in Carrying Amount of Goodwill (Detail) HTML 61K
85: R69 Amortization Expense Related to Intangible Assets HTML 52K
(Detail)
86: R70 Estimated Future Amortization Expense for HTML 54K
Intangible Assets (Detail)
87: R71 Asset Impairment Charges - Additional Information HTML 57K
(Detail)
88: R72 Asset Impairment Charges (Detail) HTML 43K
89: R73 Debt Outstanding Excluding Capital Lease HTML 60K
Obligations (Detail)
90: R74 Interest Expense (Detail) HTML 50K
91: R75 Debt - Additional Information (Detail) HTML 204K
92: R76 Interest Expense Related to Notes (Detail) HTML 52K
93: R77 Summary of Future Payments under Notes and Senior HTML 75K
Secured Credit Facilities (Detail)
94: R78 Summary of Future Payments under Notes and Senior HTML 41K
Secured Credit Facilities (Parenthetical) (Detail)
95: R79 Geographic Breakdown of Income (Loss) Before HTML 49K
Income Tax Benefits (Detail)
96: R80 Components of Provision (Benefit) for Income Taxes HTML 73K
(Detail)
97: R81 Income Taxes - Additional Information (Detail) HTML 131K
98: R82 Taxes Computed at Statutory Federal Income Tax HTML 102K
Rate Reconciled to Provision for Income Taxes
(Detail)
99: R83 Components of Deferred Tax Assets and Liabilities HTML 82K
(Detail)
100: R84 Deferred Tax Assets (Liabilities) Classified in HTML 47K
Consolidated Balance Sheets (Detail)
101: R85 Change in the Amount of Unrecognized Tax Benefits HTML 55K
(Detail)
102: R86 Recognized Interest and Penalties Related to HTML 40K
Uncertain Tax Positions (Detail)
103: R87 Amount of Interest and Penalties Included in HTML 40K
Consolidated Balance Sheets (Detail)
104: R88 Stock Award Plans - Additional Information HTML 103K
(Detail)
105: R89 Stock-Based Compensation Expense (Detail) HTML 54K
106: R90 Activity for Restricted Stock Units (Detail) HTML 65K
107: R91 Activity for Restricted Stock Awards (Detail) HTML 59K
108: R92 Stock Options Outstanding (Detail) HTML 69K
109: R93 Weighted Average Grant Date Fair Value Information HTML 54K
and Related Valuation Assumptions (Detail)
110: R94 Stock Option Activity (Detail) HTML 43K
111: R95 Stock Option Awards (Detail) HTML 68K
112: R96 Stockholders' Equity - Additional Information HTML 97K
(Detail)
113: R97 Components of Accumulated Other Comprehensive Loss HTML 69K
(Detail)
114: R98 Components of Accumulated Other Comprehensive Loss HTML 47K
(Parenthetical) (Detail)
115: R99 Income Tax Effects Related to Components of Other HTML 127K
Comprehensive Loss (Detail)
116: R100 Fair Value and Balance Sheet Locations - (Detail) HTML 58K
117: R101 Derivative Financial Instruments - Additional HTML 90K
Information (Detail)
118: R102 Derivatives Instruments Designated as Cash Flow HTML 59K
Hedges - (Detail)
119: R103 Net Impact of Changes in Fair Value of Call Option HTML 46K
and Embedded Cash Conversion Option - (Detail)
120: R104 Rent Expense (Detail) HTML 40K
121: R105 Future Commitments under Capital and Operating HTML 84K
Leases (Detail)
122: R106 Commitments - Additional Information (Detail) HTML 41K
123: R107 Summary of Expense Incurred under Atos Agreement HTML 46K
(Detail)
124: R108 Business Segments - Additional Information HTML 42K
(Detail)
125: R109 Revenues and Income from Operations Related to HTML 62K
Segment Within Reconciliation to Consolidated
Amounts (Detail)
126: R110 Supplemental Disclosures (Detail) HTML 45K
127: R111 Accrued Expenses (Detail) HTML 47K
128: R112 Supplemental Disclosures - Additional Information HTML 39K
(Detail)
129: R113 Revenues by Geographic Area (Detail) HTML 52K
130: R114 Long-Lived Assets by Geographic Area (Detail) HTML 50K
131: R115 Contingencies - Additional Information (Detail) HTML 51K
132: R116 North American Site Consolidation Plan - HTML 57K
Additional Information (Detail)
133: R117 Quarterly Financial Information (Unaudited) HTML 94K
(Detail)
134: R118 Quarterly Financial Information (Unaudited) HTML 49K
(Parenthetical) (Detail)
135: R119 Schedule II - Valuation And Qualifying Accounts HTML 48K
(Detail)
137: XML IDEA XML File -- Filing Summary XML 258K
136: EXCEL IDEA Workbook of Financial Reports XLSX 170K
11: EX-101.INS XBRL Instance -- mdrx-20151231 XML 7.73M
13: EX-101.CAL XBRL Calculations -- mdrx-20151231_cal XML 317K
14: EX-101.DEF XBRL Definitions -- mdrx-20151231_def XML 1.09M
15: EX-101.LAB XBRL Labels -- mdrx-20151231_lab XML 2.07M
16: EX-101.PRE XBRL Presentations -- mdrx-20151231_pre XML 1.78M
12: EX-101.SCH XBRL Schema -- mdrx-20151231 XSD 294K
138: ZIP XBRL Zipped Folder -- 0001564590-16-013600-xbrl Zip 371K
 | Download this zipped .zip folder |
| Files: | mdrx-20151231.xml mdrx-20151231.xsd mdrx-20151231_cal.xml mdrx-20151231_def.xml mdrx-20151231_lab.xml mdrx-20151231_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/22 Veradigm Inc. 10-K/A 12/31/21 12:4M Donnelley … Solutions/FA 2/25/22 Veradigm Inc. 10-K 12/31/21 150:28M Donnelley … Solutions/FA 2/26/21 Veradigm Inc. 10-K 12/31/20 165:35M ActiveDisclosure/FA 8/15/16 SEC UPLOAD¶ 9/13/17 1:36K Veradigm Inc. 6/22/16 SEC UPLOAD¶ 9/13/17 1:142K Veradigm Inc. 5/12/16 SEC UPLOAD¶ 9/13/17 1:41K Veradigm Inc. 4/19/16 SEC UPLOAD¶ 9/13/17 1:157K Veradigm Inc. |